CRT 2024

The Case of EVOQUE | Summary of TRISCEND Studies and the FDA IFU

Speaker(s)

• 

  Raj Makkar, MD, FSCAI

  Vice President of Cardiovascular Innovation and Intervention
  Cedars-Sinai Medical Center
  Los Angeles, California, United States

  Disclosure information not submitted.